News - Page 171 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development

Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development

Post published:June 17, 2021
Post category:Press Release

Read more about the article MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board

MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board

Post published:June 17, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET

Post published:June 17, 2021
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021

Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021

Post published:June 17, 2021
Post category:Press Release

Read more about the article MYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics

MYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics

Post published:June 17, 2021
Post category:Press Release

Read more about the article atai Life Sciences Announces Pricing of Upsized Initial Public Offering

atai Life Sciences Announces Pricing of Upsized Initial Public Offering

Post published:June 17, 2021
Post category:Press Release

Read more about the article MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression

MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression

Post published:June 17, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.

Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.

Post published:June 16, 2021
Post category:Press Release

Read more about the article Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM), a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation

Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM), a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation

Post published:June 16, 2021
Post category:Press Release

Read more about the article Mydecine Unveils Artificial Intelligence Drug Discovery Program

Mydecine Unveils Artificial Intelligence Drug Discovery Program

Post published:June 16, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.